🇺🇸 FDA

Intelligence Platform

Patents

Browse 15 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 12331293

Bispecific antisense oligonucleotides for dystrophin exon skipping

BIOMARIN TECHNOLOGIES B.V. · Granted Tue Jun 17 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 12 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11427820

Methods and means for efficient skipping of exon 45 in Duchenne muscular dystrophy pre-mRN

BIOMARIN TECHNOLOGIES B.V. · Granted Tue Aug 30 2022 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 25 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11034956

Oligonucleotide comprising an inosine for treating DMD

BIOMARIN TECHNOLOGIES B.V. · Granted Tue Jun 15 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 10 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10913946

RNA modulating oligonucleotides with improved characteristics for the treatment of Duchenn

BIOMARIN TECHNOLOGIES B.V. · Granted Tue Feb 09 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 04 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10876114

Methods and means for efficient skipping of at least one of the following exons of the hum

BIOMARIN TECHNOLOGIES B.V. · Granted Tue Dec 29 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 24 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10689646

Treatment of genetic disorders associated with DNA repeat instability

BIOMARIN TECHNOLOGIES B.V. · Granted Tue Jun 23 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 18 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10533171

Oligonucleotide comprising an inosine for treating DMD

BIOMARIN TECHNOLOGIES B.V. · Granted Tue Jan 14 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 09 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10246707

Method for efficient exon (44) skipping in duchenne muscular dystrophy and associated mean

BIOMARIN TECHNOLOGIES B.V. · Granted Tue Apr 02 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 28 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10179912

RNA modulating oligonucleotides with improved characteristics for the treatment of duchenn

BIOMARIN TECHNOLOGIES B.V. · Granted Tue Jan 15 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 10 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9926557

Methods and means for efficient skipping of exon 45 in Duchenne muscular dystrophy pre-mRN

BIOMARIN TECHNOLOGIES B.V. · Granted Tue Mar 27 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 22 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9890379

Treatment of genetic disorders associated with DNA repeat instability

BIOMARIN TECHNOLOGIES B.V. · Granted Tue Feb 13 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 08 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9745576

RNA modulating oligonucleotides with improved characteristics for the treatment of neuromu

BIOMARIN TECHNOLOGIES B.V. · Granted Tue Aug 29 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 24 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9528109

Methods and means for efficient skipping of exon 45 in duchenne muscular dystrophy pre-mRN

BIOMARIN TECHNOLOGIES B.V. · Granted Tue Dec 27 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 22 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9499818

Methods and means for efficient skipping of at least one of the exons 51-53, 55, 57 and 59

BIOMARIN TECHNOLOGIES B.V. · Granted Tue Nov 22 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 17 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9243245

Means and methods for counteracting muscle disorders

BIOMARIN TECHNOLOGIES B.V. · Granted Tue Jan 26 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 21 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted